Colgate-Palmolive Company

No Beneish M-Score, Piotroski F-Score, Altman Z-Score or Fog Index is on file for Colgate-Palmolive in this data, so this synthesis does not report or interpret any forensic score. Readers who want that layer should check the company's own filings and independent screens directly rather than rely on a number not provided here. What the filing text does show is a large, mature consumer products business. The 2025 revenue figure of $20.38 billion compares with $15.54 billion in 2018, an increase of about 31% over seven years, but growth has slowed: the 2025 gain over 2024 was roughly 1.4%, compared with about 3.3% in 2024. The risk factor discussion names inflationary pressure, tariffs including those tied to 2025 executive orders, retaliatory measures, currency movements and the war in Ukraine as factors that have affected consumption and product mix. The Eurasia business was about 1% of 2025 net sales and about 2% of operating profit, and Venezuela results have not been consolidated since December 31, 2015, so those items are small in the numbers but still disclosed as ongoing risks. The Q1 2026 10-Q lists no material change in risk factors and incorporates a legal matter by reference to Note 10, Contingencies, which is not included in the excerpt, so its scale cannot be assessed from this data. Capital allocation is the most concrete management action in the excerpt: the 2025 Program authorized up to $5 billion, and repurchase activity in the quarter was concentrated in February and March. The approximate dollar value of shares still available under the programs fell from $4,087 million in the January row of the table to $3,809 million in the March row. A careful reader would weigh that repurchase activity against the revenue growth rate and the foreign currency and retailer-pressure risks described above.

Catalyst.The excerpt of the first-quarter 2026 Form 10-Q does not include a results discussion, so the clearest recent signal is the annual revenue series. Revenues were $20.38 billion for 2025, up from $20.1 billion in 2024, roughly 1.4% growth. That follows about 3.3% growth in 2024 and about 8.3% in 2023, when revenues were $19.46 billion. The MD&A excerpt describes an ongoing upgrade of the enterprise IT system and a move of IT infrastructure to the cloud, which management says has not had and is not expected to have a material impact on internal control. Capital return is also visible: the Board authorized a new program of up to $5 billion on March 20, 2025, and in the first quarter of 2026 the company bought 3,386,850 shares at an average price of $90.28.

Hidden risk.The risk factors describe a business that depends heavily on markets outside the United States, with approximately two-thirds of net sales originating abroad. Management cites inflation, currency swings, tariffs, sanctions and political instability, and says its hedging and pricing actions have not and may not fully offset currency effects. The 10-Q states there is no material change to the 10-K risk factors, so these remain current. A less visible tension is customer concentration: key retailers have greater bargaining strength and have demanded higher trade discounts, allowances and slotting fees that have led to reduced sales or profitability in certain markets. Readers may want to look at how those costs appear in the segment and margin disclosures in the full filing.